NCT02009085View on ClinicalTrials.gov

Pilot Study to Determine Feasibility of Benign and Malignant Skin Lesion Detection.

CompletedOBSERVATIONAL
Enrollment

126

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Skin Lesions
Sponsors

Lead Sponsor

Orlucent, Inc

Collaborators (1)

Clalit Health Services
All Listed Sponsors
collaborator

Clalit Health Services

OTHER

lead

Orlucent, Inc

INDUSTRY

NCT02009085 - Pilot Study to Determine Feasibility of Benign and Malignant Skin Lesion Detection. | Biotech Hunter | Biotech Hunter